Peter A. Calabresi
Affiliations: | Neurology | Johns Hopkins University, Baltimore, MD |
Area:
multiple sclerosisGoogle:
"Peter Calabresi"Mean distance: 15.65 (cluster 17)
Children
Sign in to add trainee| Sachin Gadani | post-doc | Johns Hopkins | |
| Daniel S. Reich | post-doc | 2004-2009 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bagnato F, Sati P, Hemond CC, et al. (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a Journal of Neurology |
| Daboul L, O'Donnell CM, Amin M, et al. (2023) A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231214360 |
| Ladakis DC, Reyes-Mantilla MI, Gadani SP, et al. (2023) Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231213164 |
| Thompson AJ, Moccia M, Amato MP, et al. (2023) Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231196786 |
| Gadani SP, Calabresi PA. (2023) The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border. Cell. 186: 3524-3526 |
| Clark KA, O'Donnell CM, Elliott MA, et al. (2023) Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging |
| Newsome SD, Tian F, Shoemaker T, et al. (2023) A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
| Ehrhardt H, Lambe J, Moussa H, et al. (2023) Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post-Hoc Analyses of the SPRINT-MS Trial. Neurology |
| Maggi P, Bulcke CV, Pedrini E, et al. (2023) B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. Ebiomedicine. 94: 104701 |
| Gill AJ, Schorr EM, Gadani SP, et al. (2023) Emerging imaging and liquid biomarkers in multiple sclerosis. European Journal of Immunology. e2250228 |